HHS-OIG – Page 4 – Policy & Medicine

HHS OIG Report Finds Providers Inappropriately Billed Medicare During Pandemic

Pfizer Seeking to Rewrite Anti-Kickback Interpretations

HHS OIG Finds that NIH Fails to Hold Researchers Accountable

Policy and Medicine Compliance Update October, 2022 Issue Covers HHS Self Disclosure and DOJ Enforcement Policies, Omnicare FCA Case, and Stem Cell Research

HHS OIG Concludes it Will Not Sanction Company Offering MA Beneficiaries $25 Gift Card for Completing a Survey

HHS OIG Audit Finds that NIH Did Not Ensure All Clinical Trial Results Were Reported as Required

HHS OIG Finds Inaccuracies and Limitations in Medicare Enrollment Data

HHS OIG Finds that Eight Drug Codes Met CMS’ Price Substitution Criteria

HHS OIG Reviews Prior Authorization Denials

HHS OIG Releases Report on MAO Performance